Sidekick Health Germany develops digital health applications and medical therapies that aim to improve long-term patient outcomes and enable broad access to care. The company focuses on combining behavioral psychology, neuroscience and AI to create data-driven, evidence-based digital therapeutics.

Through prescription-approved products such as zanadio (released October 2020) — the first digital obesity therapy on prescription approved by the German Federal Institute for Drugs and Medical Devices (BfArM) — Sidekick Health Germany works to close supply gaps in the healthcare system and support sustainable lifestyle change.

We design clinically validated programs to achieve durable behavioral change and measurable health improvement. The company highlights ISO 27001 certification and a portfolio of approved digital therapeutic products, serving tens of thousands of patients.

Sidekick Health Germany collaborates with healthcare organizations, industry partners and public sponsors to scale digital therapies across indications. For current openings and career information see the career page.